Share with your friends
The Life Sciences asset swap opportunity

The Life Sciences asset swap opportunity

The Life Sciences asset swap opportunity

Life sciences companies face rising R&D costs, downward pricing pressure, and increasing regulations, along with geopolitical events like US tax reform. As they rationalize portfolios and focus on fewer segments, there has been a rise in M&A - but is now the right time to reconsider asset swaps as a viable alternative?

In this paper we argue that asset swaps can help swiftly and efficiently build leadership in specific therapeutic categories, looking at the main challenges of this type of transaction and examining how best to execute these deals successfully.

Why should you consider asset swaps?

Asset swaps have a number of potential advantages over traditional M&A:

  • Targeted focus
    • Asset swaps can boost growth in core businesses and offload unwanted assets to improve ROI. They also provide very high deal precision, as they only include products or business units that each party specifically selects.
  • Portfolio speed-building
    • Through simultaneously acquiring and divesting, asset swaps let both parties build critical mass swiftly in line with their business strategies and product portfolios.
  • Financial efficiency
    • In traditional M&A, companies are under pressure to invest divestment funds to generate shareholder value - which can lead to hasty decisions. In asset swaps, however, new businesses are acquired instantly and contribute immediately to revenue and earnings. And with similar priced entities being exchanged, there is less need to either use company cash or seek additional funding from capital markets.
  • Mitigated risk
    • With an asset swap, there is no requirement to acquire superfluous resources from the selling company, minimizing historic liabilities like tax treatment.

Achieving a successful asset swap

Asset swaps should be especially beneficial to companies with a clear strategy of category leadership. It is important to find a partner with mutual goals, and to build trust and reciprocity, putting aside traditional competitive rivalries to ensure a free information flow and agreed asset valuation.

By focusing on capturing post-deal value, both parties can coordinate integration with separation to transition the new assets into each other's businesses.

Connect with us

Related content